These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8815790)

  • 1. Glucokinase mutations, insulin secretion, and diabetes mellitus.
    Bell GI; Pilkis SJ; Weber IT; Polonsky KS
    Annu Rev Physiol; 1996; 58():171-86. PubMed ID: 8815790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
    Byrne MM; Sturis J; Clément K; Vionnet N; Pueyo ME; Stoffel M; Takeda J; Passa P; Cohen D; Bell GI
    J Clin Invest; 1994 Mar; 93(3):1120-30. PubMed ID: 8132752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
    Massa O; Meschi F; Cuesta-Munoz A; Caumo A; Cerutti F; Toni S; Cherubini V; Guazzarotti L; Sulli N; Matschinsky FM; Lorini R; Iafusco D; Barbetti F;
    Diabetologia; 2001 Jul; 44(7):898-905. PubMed ID: 11508276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus.
    Vionnet N; Stoffel M; Takeda J; Yasuda K; Bell GI; Zouali H; Lesage S; Velho G; Iris F; Passa P
    Nature; 1992 Apr; 356(6371):721-2. PubMed ID: 1570017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
    Hattersley AT
    Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus.
    Hussain K
    Rev Endocr Metab Disord; 2010 Sep; 11(3):179-83. PubMed ID: 20878480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.
    Velho G; Froguel P; Clement K; Pueyo ME; Rakotoambinina B; Zouali H; Passa P; Cohen D; Robert JJ
    Lancet; 1992 Aug; 340(8817):444-8. PubMed ID: 1354782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucokinase gene abnormalities in maturity-onset diabetes of the young (MODY) and late-onset NIDDM].
    Odawara M
    Nihon Rinsho; 1994 Oct; 52(10):2580-6. PubMed ID: 7983782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MODY diabetes--a monogenic developmental and functional disturbance of pancreatic beta cells].
    Miettinen PJ; Tuomi T
    Duodecim; 2012; 128(19):1989-98. PubMed ID: 23155750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific insulin and proinsulin secretion in glucokinase-deficient individuals.
    Pardini VC; Velho G; Reis R; Purisch S; Blanché H; Vieira JG; Moisés RC
    Braz J Med Biol Res; 1999 Apr; 32(4):427-30. PubMed ID: 10347805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus.
    Velho G; Froguel P
    Diabetes Metab; 1997 Mar; 23 Suppl 2():34-7. PubMed ID: 9162575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-insulin dependent diabetes in children and adolescents].
    Njølstad PR; Søvik O; Bell GI; Cockburn BN; Følling I; Sagen J
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1054-7. PubMed ID: 9531829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
    Stride A; Hattersley AT
    Ann Med; 2002; 34(3):207-16. PubMed ID: 12173691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical characteristics of maturity-onset diabetes of the young.
    Giuffrida FM; Reis AF
    Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion.
    Efrat S; Leiser M; Wu YJ; Fusco-DeMane D; Emran OA; Surana M; Jetton TL; Magnuson MA; Weir G; Fleischer N
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2051-5. PubMed ID: 7510884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.